Sol-Gel Technologies Ltd. SLGL
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +62.20%
- 1 year
- +84.73%
- Open
- 69.49
- Prev close
- 68.66
- Mkt cap
- 223.78M
- Vol
- 33.52K
- Avg vol
- 53.84K
- EPS
- -5.61
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 67.14
- High
- 70.15
- Forward P/E
- -3.44
- Beta
- 1.60
- Short ratio
- 0.59
- Inst. own
- 19.35%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 16, 2024
- 50-d avg
- 0.55476
- 200-d avg
- 0.70915
- 1y target
- 5.00
3M chart
Signals (21)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 2 days ago |
| MACD: Buy Signal | Oct 27, 2026 | 5 days ago |
| SMA: Bullish | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 3 weeks ago |
| SMA: Bullish | Sep 29, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 25, 2026 | 1 month ago |
| RSI: Oversold | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 21, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
Key statistics
- Market cap
- 45.97M
- Enterprise value
- -14.73M
- Trailing P/E
- 0.00
- Forward P/E
- -3.44
- PEG ratio
- 0.00
- Price / sales
- 7.01
- Price / book
- 1.19
- EPS (TTM)
- -0.34
- Beta
- 1.60
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -227.40%
- Revenue (TTM)
- 6.56M
- Revenue growth
- 814.60%
- Free cash flow
- -12.43M
- Total cash
- 30.47M
- Total debt
- 1.39M
- Return on equity
- -35.85%
- Shares outstanding
- 27.86M
- Short % of float
- 0.31%
- 50-day average
- 0.55476
- 200-day average
- 0.70915
Analyst view
Consensus: none
- Target (low)
- 4.00
- Target (mean)
- 5.00
- Target (high)
- 6.00
- Strong buy2
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 16, 2024
Expected Aug 16, 2024. Consensus EPS estimate -0.11.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 15, 2024 | Sep 1, 2024 | -0.13 | -0.01 | +0.12 | +92.31% |
| Aug 16, 2024 | Jun 1, 2024 | -0.20 | 0.07 | +0.27 | +135.00% |
| Aug 16, 2024 | Jun 1, 2024 | -0.20 | — | — | — |
| May 20, 2024 | Mar 1, 2024 | -0.15 | -0.23 | -0.08 | -53.33% |
| May 20, 2024 | Mar 1, 2024 | -0.15 | — | — | — |
| Mar 13, 2024 | Dec 1, 2023 | -0.16 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 19, 2024 | Raymond James | down | Strong Buy | Outperform |
| May 22, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| May 20, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Nov 13, 2023 | HC Wainwright & Co. | main | Buy | Buy |
| Aug 14, 2023 | HC Wainwright & Co. | main | Buy | Buy |
| Aug 11, 2023 | Raymond James | main | Strong Buy | Strong Buy |
About Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Israel
- Website
- sol-gel.com
News
- Sol-Gel Technologies (NASDAQ:SLGL) & Iterum Therapeutics (NASDAQ:ITRM) Head to Head Review
- Sol-Gel Technologies (NASDAQ:SLGL) Stock Keeps “Buy” Rating at HC Wainwright
- HC Wainwright & Co. Reiterates Buy on Sol-Gel Technologies, Maintains $110 Price Target
- Head to Head Analysis: Sol-Gel Technologies (NASDAQ:SLGL) vs. Trulieve Cannabis (NYSE:TRLV)
- New Strong Buy Stocks for October 16th
- Sol-Gel Eyes 2028 Launch as SGT-610 Nears Pivotal Gorlin Syndrome Data
- Sol-Gel Technologies Ltd. (SLGL) Analyst/Investor Day Transcript
- This Entegris Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
- Cantor Fitzgerald Initiates Coverage On Sol-Gel Technologies with Overweight Rating
- SolGel Technologies (SLGL) Upgraded to Buy: Here's Why
Your note
Sign in to keep a note on SLGL — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Phoenix Holdings Ltd. | 8.87% | 2,470,192 | 4.08M | Sep 29, 2024 |
| Migdal Insurance & Financial Holdings Ltd. | 4.41% | 1,227,548 | 2.03M | Sep 29, 2024 |
| Harel Insurance Investments & Financial Services Ltd. | 3.30% | 920,333 | 1.52M | Sep 29, 2024 |
| Yelin Lapidot Holdings Management Ltd. | 0.82% | 229,178 | 378.14K | Sep 29, 2024 |
| Prosperity Wealth Management, Inc. | 0.59% | 163,400 | 269.61K | Sep 29, 2024 |
| Raymond James Financial Services Advisors, Inc. | 0.32% | 88,461 | 145.96K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.05% | 13,406 | 22.12K | Oct 30, 2024 |